Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Psyence Biomedical Ltd. (PBM)

Intensity Therapeutics Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Psyence Biomedical Ltd. is the larger, with a market value of $11.2M against $10.1M — 1.1× the size. Intensity Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Across the 10 metrics below, Psyence Biomedical Ltd. leads on 6 and Intensity Therapeutics Inc. on 4.

Valuation

Metric INTS PBM Biotechnology median
P/E n/m 0.13 10.26
P/S n/m n/m 9.18
P/B 0.87 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.12 1.91 0.65
EV/Sales n/m n/m 8.98
Earnings yield (164.06%) 759.84% (34.89%)
Free cash flow yield (111.37%) (1,147.64%) (24.52%)

Profitability

Metric INTS PBM Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.88%) (23.52%) (50.12%)
Return on assets (139.85%) (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INTS PBM Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 70.74% (138.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS PBM Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 8.09 4.89
Net debt to EBITDA 0.99 1.20 1.01

Dividend

Metric INTS PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INTS PBM Biotechnology median
Market cap 10.12m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack